Form 4 for VOR Vor Biopharma Inc.
Accepted 2021-08-19 00:00:00 ET · period of report 2021-08-17 · accession 0001209191-21-052514 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-19 | 2021-08-17 | VOR | Chakraborty Tirtha | CSO | M - OptEx | $1.36 | +17.4K | 21.0K | +494% | +$23.7K |
| D | 2021-08-19 | 2021-08-17 | VOR | Chakraborty Tirtha | CSO | M - OptEx | $0.00 | -17.4K | 28.8K | -38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-17 | M | A | 17,446 | $1.36 | 20,980 | D | — | — | |
| 2 | Derivative | Employee Stock Option (right to buy) | 2021-08-17 | M | D | 17,446 | $0.00 | 28,800 | D | $1.36 · — to 2029-09-24 | 17,446 Common Stock | (F1) 1/4th of the shares underlying the option vested on September 23, 2020, with the remainder vesting in equal monthly installments over 3 years, provided that the Reporting Person remains continuously engaged by the Issuer on each such vesting date. |